BOLT vs BXP · rev $7.7M vs rev $3.48B
Bolt Biotherapeutics (BOLT) versus Boston Properties Inc (BXP) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
BOLT currently screens at market cap $11.3M. BXP currently screens at market cap $12.12B.
Not investment advice. Open the BOLT and BXP stock pages for the full models.
Not investment advice.